目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL OPTICAL GENOME MAPPING MARKET, BY PRODUCT
6.1. Overview
6.2. Instruments
6.3. Consumables and Reagents
6.4. Software
6.5. Services

7. GLOBAL OPTICAL GENOME MAPPING MARKET, BY APPLICATION
7.1. Overview
7.2. Structural Variant Detection
7.3. Genome Assembly
7.4. Microbial Strain Typing
7.5. Others

8. GLOBAL OPTICAL GENOME MAPPING MARKET, BY END-USER
8.1. Overview
8.2. Biotechnology and Pharmaceutical Companies
8.3. Clinical Laboratories
8.4. Academic Research Institutes
8.5. Others

9. GLOBAL OPTICAL GENOME MAPPING MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Optical Genome Mapping Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Optical Genome Mapping Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. Bionano Genomics
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Nucleome Informatics Private Limited
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Praxis Genomics, LLC
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. SourceBio International Limited (Source BioScience)
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. MEDGENOME
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. INRAE (French Plant Genomic Resources Center (CNRGV))
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. PerkinElmer (PerkinElmer Genomics)
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Genohub Inc
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. HOFKENS LAB
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Cerba
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL OPTICAL GENOME MAPPING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL OPTICAL GENOME MAPPING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 US: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 US: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 US: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 12 CANADA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 13 CANADA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 CANADA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 15 EUROPE: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 EUROPE: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 17 EUROPE: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 18 GERMANY: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 19 GERMANY: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 20 GERMANY: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 21 FRANCE: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 22 FRANCE: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 23 FRANCE: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 24 ITALY: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 25 ITALY: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 26 ITALY: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 27 SPAIN: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 28 SPAIN: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 29 SPAIN: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 30 UK: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 31 UK: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 32 UK: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 33 REST OF EUROPE: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 34 REST OF EUROPE: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 35 REST OF EUROPE: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 36 ASIA-PACIFIC: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 37 ASIA-PACIFIC: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 38 ASIA-PACIFIC: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 39 JAPAN: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 40 JAPAN: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 41 JAPAN: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 42 CHINA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 43 CHINA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 44 CHINA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 45 INDIA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 46 INDIA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 47 INDIA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 48 AUSTRALIA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 49 AUSTRALIA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 50 AUSTRALIA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 53 SOUTH KOREA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 60 MIDDLE EAST: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 63 AFRICA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 64 AFRICA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 65 AFRICA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 66 LATIN AMERICA: OPTICAL GENOME MAPPING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 67 LATIN AMERICA: OPTICAL GENOME MAPPING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 68 LATIN AMERICA: OPTICAL GENOME MAPPING MARKET, BY END-USER, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL OPTICAL GENOME MAPPING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL OPTICAL GENOME MAPPING MARKET
FIGURE 4 GLOBAL OPTICAL GENOME MAPPING MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL OPTICAL GENOME MAPPING MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL OPTICAL GENOME MAPPING MARKET, SHARE (%), BY END-USER, 2023
FIGURE 7 GLOBAL OPTICAL GENOME MAPPING MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: OPTICAL GENOME MAPPING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: OPTICAL GENOME MAPPING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: OPTICAL GENOME MAPPING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: OPTICAL GENOME MAPPING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL OPTICAL GENOME MAPPING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 BIONANO GENOMICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BIONANO GENOMICS: SWOT ANALYSIS
FIGURE 15 NUCLEOME INFORMATICS PRIVATE LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 NUCLEOME INFORMATICS PRIVATE LIMITED: SWOT ANALYSIS
FIGURE 17 PRAXIS GENOMICS, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 PRAXIS GENOMICS, LLC: SWOT ANALYSIS
FIGURE 19 SOURCEBIO INTERNATIONAL LIMITED (SOURCE BIOSCIENCE): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 SOURCEBIO INTERNATIONAL LIMITED (SOURCE BIOSCIENCE): SWOT ANALYSIS
FIGURE 21 MEDGENOME: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 MEDGENOME: SWOT ANALYSIS
FIGURE 23 INRAE (FRENCH PLANT GENOMIC RESOURCES CENTER (CNRGV)).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 INRAE (FRENCH PLANT GENOMIC RESOURCES CENTER (CNRGV)).: SWOT ANALYSIS
FIGURE 25 PERKINELMER (PERKINELMER GENOMICS): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 PERKINELMER (PERKINELMER GENOMICS): SWOT ANALYSIS
FIGURE 27 GENOHUB INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 GENOHUB INC: SWOT ANALYSIS
FIGURE 29 HOFKENS LAB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 HOFKENS LAB: SWOT ANALYSIS
FIGURE 31 CERBA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 CERBA: SWOT ANALYSIS